Labetalol: A Descriptive Analysis of Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)

Documenti analoghi

• Descriptive Analysis of Ranolazine Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  di: Nehad Jaser Ahmed
  Pubblicazione: (2026)
• Descriptive Analysis of DALTEPARIN Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  di: Nehad Jaser Ahmed
  Pubblicazione: (2026)
• DOFETILIDE Descriptive Analysis of Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  di: Nehad Jaser Ahmed
  Pubblicazione: (2026)
• Prazosin Adverse Events: A Descriptive Analysis of the FDA Adverse Event Reporting System (FAERS)
  di: Nehad Jaser Ahmed
  Pubblicazione: (2026)
• HYDROCHLOROTHIAZIDE ADVERSE EVENTS A Descriptive Analysis of Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  di: Nehad Jaser Ahmed
  Pubblicazione: (2026)